icon-folder.gif   Conference Reports for NATAP  
 
  EASL - The International Liver Congress 2014
49th Annual Meeting of the European
Association for the Study of the Liver
London, United Kingdom  April 9-13
Back grey_arrow_rt.gif
 
 
 
Futility Testing at Treatment Week 8 in Patients With Hepatitis C Virus (HCV) Genotype 1 Infection Receiving Boceprevir: A Post Hoc Analysis
 
 
  Reported by Jules Levin
EASL 2014 April 9-13 London, UK
 
Ira M. Jacobson,1 Marcelo Silva,2 Savino Bruno,3 Jose-Luis Calleja,4 Bruce Bacon,5 Rafael Esteban,6 Fred Poordad,7 Jean-Pierre Bronowicki,8 Mark S. Sulkowski,9 John M. Vierling,10 Steven Flamm,11 Lynn Colvard,12 Seth Thompson,12 Kenneth Koury,12 Frans A. Helmond,12 Katia Alves,12 Janice Wahl12 1Weill Cornell Medical College, New York, NY, USA; 2Hospital Universitario Austral, Pilar, Argentina; 3Fatebenefratelli e Oftalmico Hospital, Milan, Italy; 4Hospital Universitario Puerta de Hierro, Madrid, Spain; 5Saint Louis University School of Medicine, St Louis, MO, USA; 6Vall d'Hebron University Hospital, Barcelona, Spain; 7The Texas Liver Institute, University of Texas Health Science Center, San Antonio, TX, USA; 8Centre Hospitalier Universitaire de Nancy, Universite Henri Poincare, Nancy, France; 9Johns Hopkins University School of Medicine, Baltimore, MD, USA; 10Baylor College of Medicine, Houston, Texas, USA; 11Northwestern Feinberg School of Medicine, Chicago, IL, USA; 12Merck & Co., Inc, Whitehouse Station, NJ, USA

EASL1.gif

EASL2.gif

EASL3.gif

EASL4.gif

EASL5.gif

EASL6.gif

EASL7.gif

EASL8.gif

EASL9.gif

EASL10.gif